Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Arrabal

Showing results (101-110 of 102) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 102 results.
Actas Urologicas Espanolas|May 26, 2026
Improving Long-Term Monitoring in NMIBC: Digital Uromonitor® (dUM) as a Complementary Tool to Cystoscopy for Two-Year Recurrence Risk StratificationJ Rubio-Briones, F Guerrero Ramos, A Mercadé Sánchez, et al.
Actas Urologicas Espanolas|May 28, 2013
Treatment of prostate and renal cancer with oral drugs (abiratarone and antiangiogenic agents): positioning statement from the Spanish Association of UrologyH Villavicencio, C Hernández, A Gómez, et al.
Pageof 11

Showing results (101-110 of 102) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 102 results.
Actas Urologicas Espanolas|May 26, 2026
Improving Long-Term Monitoring in NMIBC: Digital Uromonitor® (dUM) as a Complementary Tool to Cystoscopy for Two-Year Recurrence Risk StratificationJ Rubio-Briones, F Guerrero Ramos, A Mercadé Sánchez, et al.
Actas Urologicas Espanolas|May 28, 2013
Treatment of prostate and renal cancer with oral drugs (abiratarone and antiangiogenic agents): positioning statement from the Spanish Association of UrologyH Villavicencio, C Hernández, A Gómez, et al.
Pageof 11